
Centre Flags Hospital Malpractice in Supreme Court
What Happened?
The Centre has informed the Supreme Court about exorbitant hospital charges for medicines, highlighting a significant imbalance in bargaining power between patients and hospitals. The government described these practices as malpractice.
Key points
- The Centre's affidavit reveals markups on anti-cancer drugs ranging from 170% to 700%.
- Patients have limited knowledge about medicines and their prices, leading to a low bargaining position.
- The government proposed capping trade margins on non-scheduled anti-cancer medicines at 30%.
- Hospitals reportedly charge margins of 100% to 1,000% on medical consumables.
- The Supreme Court expressed concerns over the significant price disparities in essential medicines.
Key insights
- The proposed cap on anti-cancer drug prices could lead to significant savings for patients.
- Addressing pricing disparities may require broader regulatory measures beyond cancer medicines.
- The high margins on consumables could lead to increased out-of-pocket expenses for patients.
Why it matters
This issue affects patients' financial burdens and access to affordable healthcare.
Source
India Today